Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079905 | SCV000111788 | benign | not specified | 2014-05-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079905 | SCV000308445 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000079905 | SCV000538711 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Labcorp Genetics |
RCV001510954 | SCV001718119 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001582568 | SCV001821635 | benign | Hearing loss, autosomal dominant 37 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001582567 | SCV001821636 | benign | Fibrochondrogenesis 1 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001582566 | SCV001821637 | benign | Marshall syndrome | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001582565 | SCV001821638 | benign | Stickler syndrome type 2 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001510954 | SCV001907687 | benign | not provided | 2016-09-30 | criteria provided, single submitter | clinical testing |